Frontlight ResearchEarly access
CompletedPhase 2
ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
Key facts
- Who runs it
- University Hospital, Toulouse
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 4 people enrolled
- Started
- 16 Jan 2023
- Ended
- 2 Jan 2024
- Type of study
- Interventional
- Treatments tested
- Aspirin
- Record updated
- 31 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- adult patients
- non-treated immune thrombocytopenia or immune thrombocytopenia with stable treatment (at least 1 month)
- treated with aspirin daily for a cardiovascular disease; stable platelet count < 100 x 109/L
- at least one month following an arterial thrombosis
- no other antiplatelet drug and anticoagulant
- female patient with childbearing potential must have acceptable method of birth control
- affiliated or benefiting from public health insurance
Who cannot take part
- opposition to participate
- adults under guardianship or other legal protection
- deprived of their liberty by judicial or administrative decision
- pregnancy or breastfeeding
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The incidence of immune thrombocytopenia increases with older age. This population is at risk for arterial thrombosis. Due to an increased turn-over of platelets, low-dose aspirin once daily may be insufficient in this population to protect against arterial thrombosis. This study is aimed at assessing the pharmacodynamics of aspirin once daily on platelet function in these patients.
The group in the trial
- Single armTreatment being tested
Sequential variations of daily aspirin intake time
Treatment: Aspirin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 31 December 2025